GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...

Roche CEO Thomas Schinecker said in a statement on Tuesday that the company’s new $50 billion investment demonstrated its ...

ZURICH, April 22 (Reuters) - Roche (ROG.S), opens new tab said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 new jobs, in the ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.The Basel-based company, whose array of ...

Swiss pharmaceutical giant Roche has promised to export more medicine from the U.S. than it imports once a fresh $50 billion investment pledge across the States is rolled out, joining other ...

Roche, a Swiss pharmaceutical giant, will invest $50 billion in the United States over the next five years, creating 12,000 jobs and expanding manufacturing, distribution, and research.

This content was published on Oct 20, 2024 Swiss pharma giant Roche is the latest company to refocus its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.